GSK Lights Fire Under Educating Consumers On Smoking Cessation OTCs
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline says it is stepping up public relations efforts to tell consumers that its OTC smoking cessation products are not linked to problems reported with Pfizer's Rx drug Chantix